share_log

藥明康德：海外監管公告

WUXI APPTEC: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

香港交易所 ·  Mar 26 05:35
Summary by Moomoo AI
药明康德將於2024年4月2日上午10:00至11:00，透過上海證券交易所上證路演中心的視頻直播和網絡互動方式，召開2023年度業績說明會。此次業績說明會旨在讓投資者更全面深入地了解公司2023年度的業績和經營情況，並回答投資者普遍關心的問題。投資者可於2024年3月27日至4月1日16:00前，通過上證路演中心網站提問或通過電子郵件向公司投資者關係郵箱提出問題。業績說明會將由公司副董事長胡正國先生、聯席首席執行官陳民章博士和楊青博士、首席財務官施明女士等高層領導出席。會後，投資者可通過上證路演中心查看會議的召開情況及主要內容。
药明康德將於2024年4月2日上午10:00至11:00，透過上海證券交易所上證路演中心的視頻直播和網絡互動方式，召開2023年度業績說明會。此次業績說明會旨在讓投資者更全面深入地了解公司2023年度的業績和經營情況，並回答投資者普遍關心的問題。投資者可於2024年3月27日至4月1日16:00前，通過上證路演中心網站提問或通過電子郵件向公司投資者關係郵箱提出問題。業績說明會將由公司副董事長胡正國先生、聯席首席執行官陳民章博士和楊青博士、首席財務官施明女士等高層領導出席。會後，投資者可通過上證路演中心查看會議的召開情況及主要內容。
Pharmaceutical Ming Kand will hold its 2023 Annual Results Conference on April 2, 2024 from 10:00 a.m. to 11:00 a.m., via a video broadcast and web interaction at the Shanghai Stock Exchange's Aisang Road Demonstration Center. This results statement is intended to provide investors with a more comprehensive understanding of the company's 2023 performance and operations, and to answer questions of general investor concern. Investors may ask questions on the website of the Kamaishi Roadshow Centre or by email to the company's investor relations mailbox before 16:00 from 27 March to 1 April 2024. The conference will be attended by senior leaders such as Mr. Hu Zhengguo, Vice Chairman of the Company, Dr. Chen Min-chang, Co-CEO, and Dr. Yang Ching, Chief Financial Officer, Ms. Shi Ming. After the meeting, investors can view the events and main content of the meeting through the Aisei Road Performance Centre.
Pharmaceutical Ming Kand will hold its 2023 Annual Results Conference on April 2, 2024 from 10:00 a.m. to 11:00 a.m., via a video broadcast and web interaction at the Shanghai Stock Exchange's Aisang Road Demonstration Center. This results statement is intended to provide investors with a more comprehensive understanding of the company's 2023 performance and operations, and to answer questions of general investor concern. Investors may ask questions on the website of the Kamaishi Roadshow Centre or by email to the company's investor relations mailbox before 16:00 from 27 March to 1 April 2024. The conference will be attended by senior leaders such as Mr. Hu Zhengguo, Vice Chairman of the Company, Dr. Chen Min-chang, Co-CEO, and Dr. Yang Ching, Chief Financial Officer, Ms. Shi Ming. After the meeting, investors can view the events and main content of the meeting through the Aisei Road Performance Centre.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more